Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis

Authors:

Abstract
The expression of bcl‐2 protein was analysed immunohistochemically in 202 female breast carcinomas. The intensity of bcl‐2 expression was inversely related to tumour grade (PPPPP=0·0007), S‐phase fraction (P=0·00047), and apoptotic index (P=0·087). A high fraction of bcl‐2‐positive cells was related to ductal or lobular type (P=0·03) and slight nuclear pleomorphism (P=0·03). Heterogeneous expression of bcl‐2 protein was associated with high grade (P=0·02), severe nuclear pleomorphism (P=0·02), DNA aneuploidy (P=0·018), high S‐phase fraction (P=0·05), and early metastasis (P=0·03). Intense expression of bcl‐2 protein was significantly related to favourable outcome in the entire cohort (P=0·0013), as well as in axillary lymph node‐negative (ANN) tumours (P=0·0124). Long recurrence‐free periods in the entire cohort (P=0·037) and in ANN tumours (P=0·08) were confined to cases with intense expression of bcl‐2 protein. In multivariate analysis, bcl‐2 expression had no independent prognostic value in the entire cohort or in axillary lymph node‐negative breast carcinomas, whereas it was a weak independent prognostic factor in axillary lymph node‐positive breast carcinomas.

This publication has 20 references indexed in Scilit: